搜尋結果
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
CNBC· 4 日前Eli Lilly & Co.'s shares climbed in early US trading after its experimental drug for Alzhei ...
One Day To Visit Disney World? Here’s How To Do It
Forbes· 5 日前It might be a single destination, but Walt Disney World is essentially an entire city—one the ...
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 7 小時前Dave Ricks is pushing his scientists to find an even more potent anti-obesity treatment. ...
Moderna says next-generation COVID vaccine efficacy non-inferior to current shot
Reuters· 20 小時前, opens new tab said on Thursday its next-generation COVID-19 vaccine candidate showed it was ...
Refy Tapped As Selfridges’ Inaugural Partner For New Beauty Destination
Forbes· 1 日前REFY, the London-born, female-led brand cofounded by Jess Hunt and Jenna Meek has been tapped ...
Pfizer's Duchenne gene therapy fails in late-stage study
Reuters· 1 日前, opens new tab said on Wednesday its experimental gene therapy for Duchenne muscular dystrophy ...
Eli Lilly’s Alzheimer’s Drug Donanemab Is Being Considered For FDA Approval—Here’s What To Know
Forbes· 4 日前... the Food and Drug Administration could on Monday recommend Eli Lilly’s experimental ... ...
Why FDA Panel Rejected MDMA Therapy—And What’s Next For Psychedelic Medicine
Forbes· 1 日前High hopes that psychedelic medicines were finally on the pathway to regulation were dashed ...
How To Really Drive Innovation And Reignite Economic Growth
Forbes· 1 日前Earlier this week, Peter Kyle, the Labour Party’s shadow secretary of state for science, ...
Council Post: How GenAI Startups Can Kick Off A Data Flywheel To Compete With Incumbents
Forbes· 1 日前In my previous article on how startups can leverage generative AI to build a competitive ...